etorphine has been researched along with Chemical Dependence in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (39.13) | 18.7374 |
| 1990's | 10 (43.48) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Husbands, SM; Lewis, JW | 1 |
| Herz, A; Schulz, R; Wüster, M | 1 |
| Gambino, MC; Petrillo, P; Tavani, A | 1 |
| Medzihradsky, F; Smith, CB; Swain, HH; Woods, JH; Young, AM | 1 |
| Feng, JL; Hu, XY; Liu, F; Luo, Y | 1 |
| Cai, ZJ; Ge, Y; Li, M; Sun, WL | 1 |
| Kaneto, H; Takahashi, M; Tokuyama, S | 1 |
| Marcoux, GS | 1 |
| Crain, SM; Shen, KF | 2 |
| Harris, LS; Kim, SA; Martin, TJ; Smith, JE | 1 |
| Beardsley, PM; Harris, LS | 1 |
| Aceto, MD; Bowman, ER; Harris, LS | 1 |
| Li, FY; Li, Y; Wu, WR; Zheng, JW | 1 |
| Aceto, MD; Harris, LS; Ji, Z; Scates, SM | 1 |
| Evans, CJ; Monteillet-Agius, G; Saliminejad, N; Zaki, PA | 1 |
| Fang, L; Kawase, M; Morimoto, Y; Ohmori, S; Saito, S | 1 |
| Klee, WA; Lampert, A; Nirenberg, M | 1 |
| Bläsig, J; Dum, J; Herz, A; Höllt, V; Schubert, P | 1 |
| Aceto, MD; Bowman, ER; Harris, LS; Jacobson, AE; May, EL; Medzihradsky, F; Smith, CB; Woods, JH | 1 |
| Ahmed, MS; Baker, C; Cavinato, AG; Jones, R; Schinfeld, JS | 1 |
| Franklin, RB; Fujimoto, JM; Lange, DG; Roerig, SC | 1 |
| Aceto, MD; Harris, LS; Jacobson, AE; Katz, JL; Medzihradsky, F; Shiotani, S; Smith, CB; Woods, JH | 1 |
1 review(s) available for etorphine and Chemical Dependence
| Article | Year |
|---|---|
Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug Evaluation, Preclinical; Etorphine; Humans; Hydromorphone; Ligands; Morphinans; Narcotic Antagonists; Receptors, Opioid, mu; Structure-Activity Relationship; Substance-Related Disorders | 2003 |
22 other study(ies) available for etorphine and Chemical Dependence
| Article | Year |
|---|---|
Some aspects of opiate receptors.
Topics: Animals; Dendrites; Etorphine; Guinea Pigs; Humans; Ileum; Ligands; Male; Mice; Naloxone; Nerve Endings; Rats; Receptors, Neurotransmitter; Receptors, Opioid; Substance-Related Disorders; Vas Deferens | 1980 |
Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats.
Topics: Analgesics; Animals; Benzomorphans; Catatonia; Constipation; Dose-Response Relationship, Drug; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Etorphine; Gastrointestinal Motility; Humans; Male; Morphinans; Morphine; Naloxone; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Annual report: evaluation of new compounds for opioid activity (1980).
Topics: Animals; Binding Sites; Chemical Phenomena; Chemistry; Columbidae; Dose-Response Relationship, Drug; Drug Evaluation; Etorphine; Guinea Pigs; Humans; Macaca mulatta; Mice; Narcotics; National Institutes of Health (U.S.); Substance-Related Disorders; United States | 1981 |
Identification of dihydroetorphine in biological fluids by gas chromatography-mass spectrometry.
Topics: Etorphine; Gas Chromatography-Mass Spectrometry; Humans; Imidazoles; Methylene Chloride; Sensitivity and Specificity; Substance-Related Disorders | 1995 |
[Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
Topics: Administration, Sublingual; Adolescent; Adult; Analgesics, Opioid; Etorphine; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice.
Topics: Analgesics; Animals; Body Weight; Drug Tolerance; Etorphine; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Substance-Related Disorders | 1993 |
Etorphine: a new opiate of abuse?
Topics: Etorphine; Humans; Illicit Drugs; Narcotics; Substance-Related Disorders | 1996 |
Chronic morphine-treated sensory ganglion neurons remain supersensitive to the excitatory effects of naloxone for months after return to normal culture medium: an in vitro model of 'protracted opioid dependence'.
Topics: Animals; Culture Media; Etorphine; Ganglia, Spinal; Mice; Mice, Inbred Strains; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Neurons; Reference Values; Substance-Related Disorders; Time Factors | 1995 |
Potent reinforcing effects of dihydroetorphine in rats.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Etorphine; Fentanyl; Heroin; Male; Morphine; Morphine Derivatives; Rats; Rats, Inbred F344; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Etorphine; Infusions, Parenteral; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Nociceptors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine.
Topics: Analgesics, Opioid; Animals; Discrimination Learning; Dose-Response Relationship, Drug; Etorphine; Heroin; Macaca mulatta; Male; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 1997 |
Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.
Topics: Analgesics, Opioid; Animals; Etorphine; Female; Macaca mulatta; Male; Mice; Mice, Inbred ICR; Pain Threshold; Receptors, Opioid, mu; Substance-Related Disorders | 1997 |
Immunosuppressive effects of intravenous self administration of dihydroetorphine on lymphocyte functions in rats.
Topics: Animals; Cell Division; Etorphine; Immunosuppressive Agents; Injections, Intravenous; Interleukin-2; Lymphocytes; Male; Rats; Rats, Wistar; Self Administration; Spleen; Substance-Related Disorders | 1998 |
Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Etorphine; Infusions, Parenteral; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2000 |
Opiate drugs: 'guilt by association'.
Topics: Analgesics, Opioid; Animals; Central Nervous System; Etorphine; Humans; Receptors, Opioid, mu; Substance-Related Disorders | 2000 |
Tolerance to analgesia and dependence liability by topical application of dihydroetorphine to hairless rats.
Topics: Administration, Cutaneous; Analgesics, Opioid; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Tolerance; Etorphine; Formaldehyde; Inflammation; Infusions, Intravenous; Injections, Subcutaneous; Male; Morphine; Naloxone; Narcotic Antagonists; Rats; Rats, Nude; Substance-Related Disorders; Time Factors; Weight Loss | 2001 |
Tolerance and dependence evoked by an endogenous opiate peptide.
Topics: Adenylyl Cyclases; Cells, Cultured; Drug Tolerance; Enzyme Activation; Etorphine; Glioma; Humans; Hybrid Cells; Ligands; Naloxone; Neuroblastoma; Oligopeptides; Prostaglandins E; Substance-Related Disorders | 1976 |
Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant dependent rodents.
Topics: Animals; Autoradiography; Brain; Cyclopropanes; Drug Tolerance; Etorphine; Humans; Levallorphan; Mice; Morphine; Naloxone; Opium; Pain; Rats; Receptors, Drug; Stereoisomerism; Structure-Activity Relationship; Substance Withdrawal Syndrome; Substance-Related Disorders | 1975 |
Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.
Topics: Analgesics; Animals; Cinnamates; Codeine; Electric Stimulation; Etorphine; In Vitro Techniques; Macaca mulatta; Male; Mice; Mice, Inbred ICR; Morphine Derivatives; Muscle, Smooth; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders; Vas Deferens | 1989 |
Correlation between the number of placental opioid receptors, mode of delivery, and maternal narcotic use.
Topics: Cesarean Section; Delivery, Obstetric; Etorphine; Female; Humans; Kinetics; Labor, Obstetric; Maternal-Fetal Exchange; Microvilli; Pentazocine; Placenta; Pregnancy; Receptors, Opioid; Substance-Related Disorders | 1986 |
Unidirectional non-cross-tolerance (UNCT) in rats and an apparent dissociation between narcotic tolerance and physical dependence.
Topics: Analgesia; Animals; Dose-Response Relationship, Drug; Drug Implants; Drug Tolerance; Etorphine; Humans; Male; Morphine; Rats; Rats, Inbred Strains; Substance-Related Disorders | 1985 |
Pharmacological actions of the racemic and the enantiomeric 1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benz azo nines (C-homobenzomorphans).
Topics: Analgesics; Animals; Benzomorphans; Benzoquinones; Binding, Competitive; Body Weight; Etorphine; Guinea Pigs; In Vitro Techniques; Macaca mulatta; Male; Mice; Morphinans; Muscle Contraction; Muscle, Smooth; Quinones; Rats; Rats, Inbred Strains; Reaction Time; Stereoisomerism; Substance-Related Disorders | 1985 |